GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » EBIT per Share

VRHI (Veri Medtech Holdings) EBIT per Share : $ (TTM As of Dec. 2021)


View and export this data going back to . Start your Free Trial

What is Veri Medtech Holdings EBIT per Share?

Veri Medtech Holdings's EBIT per Share for the six months ended in Dec. 2021 was $0.00. Veri Medtech Holdings does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2021.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Veri Medtech Holdings's EBIT per Share or its related term are showing as below:

VRHI's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Veri Medtech Holdings's EBIT for the six months ended in Dec. 2021 was $-0.03 Mil.


Veri Medtech Holdings EBIT per Share Historical Data

The historical data trend for Veri Medtech Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veri Medtech Holdings EBIT per Share Chart

Veri Medtech Holdings Annual Data
Trend Dec21
EBIT per Share
-

Veri Medtech Holdings Semi-Annual Data
Dec21
EBIT per Share -

Veri Medtech Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Veri Medtech Holdings's EBIT per Share for the fiscal year that ended in Dec. 2021 is calculated as

EBIT per Share(A: Dec. 2021 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.033/0
=N/A

Veri Medtech Holdings's EBIT per Share for the quarter that ended in Dec. 2021 is calculated as

EBIT per Share(Q: Dec. 2021 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.033/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veri Medtech Holdings  (OTCPK:VRHI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Veri Medtech Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Veri Medtech Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Veri Medtech Holdings Business Description

Traded in Other Exchanges
N/A
Address
1660 International Dr, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.

Veri Medtech Holdings Headlines